Recursion · 2 weeks ago
Executive Director of Clinical Development
Recursion is at the forefront of reimagining drug discovery through the integration of automated cell biology and sophisticated analytics. In this role, you will lead programs across the oncology medicine portfolio and oversee the development of first-in-class molecules in precision oncology while contributing to regulatory submissions and enhancing clinical trial efficiency.
Responsibilities
Oversee the development of first-in-class/first-in-disease molecules in precision oncology
Generate and continually refine the integrated clinical development strategy for Recursion’s oncology medicine portfolio from IND to POC
Contribute to regulatory submissions and participate in regulatory agency meetings
Utilize strong therapeutic area expertise to enhance innovation and efficiency in clinical trial design and execution
Deliver medical, disease-specific, and development perspective into specific research programs or broader research initiatives
Provide scientific and medical expertise for business development assessments and due diligences
Qualification
Required
Medical Degree required and MD/PhD preferred
5+ years of experience developing, executing and analyzing Phase 1/2 Oncology trials and preferably within a biotech or pharmaceutical company
Deep knowledge and understanding of oncology and genetic diseases; precision oncology drug development paradigms, clinical pharmacology with technical and regulatory approaches
Strong networks and connections to external experts and key opinion leaders in oncology. Ability to form effective collaborations with external scientific community, academia and CROs
Effective skills directed toward driving collaboration, achieving results, influencing, and resolving conflicts across internal and external stakeholders
Highly motivated, decisive, and results-oriented individual who is proactive, resourceful, and efficient with the flexibility and creativity to excel in and contribute to a rapidly growing drug discovery and development company
Benefits
Eligible for an annual bonus
Equity compensation
Comprehensive benefits package
Company
Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives.
H1B Sponsorship
Recursion has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (6)
2023 (5)
2022 (2)
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$865.38MKey Investors
NVIDIAKinnevikLeaps by Bayer
2024-06-26Post Ipo Equity· $200M
2023-07-12Post Ipo Equity· $50M
2022-10-25Post Ipo Equity· $150M
Recent News
MenloVentures
2025-12-31
Hartford Business Journal
2025-12-30
felicis.com
2025-12-29
Company data provided by crunchbase